Jeonjin Biofarm: 2026 Q1 Revenue Up 33.7%, Net Loss Narrows, Capsule Detergent Market Share Plummets


  • 2026 Q1 revenue KRW 2.88B (vs KRW 2.16B in Q1 2025, +33.7%), net loss KRW 0.17B (vs KRW 0.38B, loss narrowed)
  • Capsule detergent market share dropped to 1.4% (from 11.8% in 2025), capacity utilization rate extremely low at 6.12%
  • Debt-to-equity ratio 6.8%, no borrowings (IBK Woori Bank line of KRW 5B unused)
  • Cash & equivalents KRW 7.06B, trade receivables KRW 1.22B, inventories KRW 1.01B
  • R&D expenses KRW 0.10B (3.55% of revenue), down from KRW 0.12B in prior year quarter
  • Export sales KRW 0.53B (18.4% of total), significantly up from KRW 0.10B in prior year quarter
  • Holds 18 patents, 45 trademarks/designs; business focuses on pest repellents and household goods
  • Related-party sales to Yuhan Corporation KRW 0.50B (vs KRW 0.90B in prior year quarter)
  • Equity KRW 17.24B, accumulated deficit KRW 28.55B (separate financial statements)

KOSDAQ Filing Information


  • Filing: Quarterly Report (2026.03)
  • Company: JEONJINBIO (110020)
  • Submission: JEONJINBIO CO., LTD.
  • Receipt: 05-15-2026